R1 RCM (NASDAQ:RCM) Stock Rating Lowered by BidaskClub

BidaskClub downgraded shares of R1 RCM (NASDAQ:RCM) from a hold rating to a sell rating in a report published on Saturday, BidAskClub reports.

A number of other analysts have also commented on RCM. ValuEngine raised shares of R1 RCM from a hold rating to a buy rating in a research note on Tuesday, March 17th. Zacks Investment Research lowered shares of R1 RCM from a hold rating to a sell rating in a research note on Thursday, May 7th. SVB Leerink began coverage on shares of R1 RCM in a research note on Monday, April 13th. They set a market perform rating and a $10.00 price objective for the company. Finally, Royal Bank of Canada began coverage on shares of R1 RCM in a research note on Monday, April 20th. They set an outperform rating and a $12.00 price objective for the company. Two analysts have rated the stock with a sell rating, one has given a hold rating and six have assigned a buy rating to the company. The stock has a consensus rating of Hold and an average target price of $13.43.

Shares of NASDAQ RCM opened at $10.85 on Friday. R1 RCM has a twelve month low of $7.12 and a twelve month high of $13.99. The company has a current ratio of 1.18, a quick ratio of 1.18 and a debt-to-equity ratio of 14.63. The company has a market capitalization of $1.24 billion, a price-to-earnings ratio of -542.23, a PEG ratio of 12.03 and a beta of 0.52. The firm has a 50-day moving average of $10.85 and a two-hundred day moving average of $11.31.

R1 RCM (NASDAQ:RCM) last issued its quarterly earnings results on Tuesday, May 5th. The healthcare provider reported $0.05 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.08 by ($0.03). R1 RCM had a net margin of 2.44% and a return on equity of 174.42%. The business had revenue of $320.50 million during the quarter, compared to analyst estimates of $318.76 million. During the same period in the previous year, the company posted ($0.04) earnings per share. R1 RCM’s revenue was up 16.1% compared to the same quarter last year. As a group, research analysts predict that R1 RCM will post 0.08 earnings per share for the current year.

Hedge funds and other institutional investors have recently bought and sold shares of the company. Sunriver Management LLC increased its holdings in R1 RCM by 47.9% in the first quarter. Sunriver Management LLC now owns 3,348,550 shares of the healthcare provider’s stock worth $30,438,000 after buying an additional 1,085,100 shares during the last quarter. FMR LLC increased its holdings in R1 RCM by 20.4% in the fourth quarter. FMR LLC now owns 2,559,391 shares of the healthcare provider’s stock worth $33,220,000 after buying an additional 433,434 shares during the last quarter. State Street Corp increased its holdings in R1 RCM by 0.6% in the first quarter. State Street Corp now owns 2,270,718 shares of the healthcare provider’s stock worth $20,641,000 after buying an additional 13,685 shares during the last quarter. Clearbridge Investments LLC increased its holdings in R1 RCM by 3.4% in the first quarter. Clearbridge Investments LLC now owns 1,943,936 shares of the healthcare provider’s stock worth $17,670,000 after buying an additional 64,390 shares during the last quarter. Finally, Geode Capital Management LLC increased its holdings in R1 RCM by 8.9% in the first quarter. Geode Capital Management LLC now owns 1,520,842 shares of the healthcare provider’s stock worth $13,824,000 after buying an additional 123,790 shares during the last quarter. 74.28% of the stock is owned by institutional investors and hedge funds.

R1 RCM Company Profile

R1 RCM Inc provides revenue cycle management (RCM) for healthcare providers in the United States. It offers end-to-end RCM services to manage their revenue cycle operations, which encompass patient registration, insurance and benefit verification, medical treatment documentation and coding, and bill preparation and collection from patients and payers.

See Also: What is a put option?

Analyst Recommendations for R1 RCM (NASDAQ:RCM)

Receive News & Ratings for R1 RCM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for R1 RCM and related companies with MarketBeat.com's FREE daily email newsletter.